Buy Stocks Easy | About Us
September 17, 2021
Buy Stocks Easy | Online Stocks

AKCA


Buy Akcea Therapeutics, Inc. Stock (symbol: AKCA) Easy Online

Company Name: Akcea Therapeutics, Inc.

Symbol: AKCA

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2017

AKCA Current Share Price

Today's AKCA ( Akcea Therapeutics, Inc. ) opening price: $19.5100

Yesterday's AKCA ( Akcea Therapeutics, Inc. ) closing price: $19.5700

Akcea Therapeutics, Inc. Stock ( symbol: AKCA ) Price Chart since IPO (2017):

12 Months Akcea Therapeutics, Inc. Stock ( symbol: AKCA ) Price Chart

Popular Questions about Akcea Therapeutics, Inc. Public Stock ( AKCA )

A: Akcea Therapeutics, Inc. stock symbol (also called stock or share ticker) is AKCA

A: Akcea Therapeutics, Inc. IPO (Initial Public Offering) took place on 2017

A: Akcea Therapeutics, Inc.'s stock (AKCA symbol) price at ther IPO (initial Public Offering) was $19.5100

Q: Is AKCA stock worth buying at the moment?

A: The AKCA stock performance since 2019 are rather disappointing. If you had bought 1 share of Akcea Therapeutics, Inc. stock (symbol: AKCA) at the beginning of 2019, at the opening share price of $26.5800, you would be left with exactly $19.5100 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Akcea Therapeutics, Inc. Stock Easy Online

Akcea Therapeutics, Inc. Stock Ticker Price Chart since IPO:





Akcea Therapeutics, Inc. Stock Price Yesterday



 


Akcea Therapeutics, Inc. Stock Price – Last Week




 


Akcea Therapeutics, Inc. Stock Price – Last Month




 


Akcea Therapeutics, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/19/1962553/0/en/Akcea-Retains-Rights-to-AKCEA-APOCIII-LRx.html
                            

                                
Akcea Retains Rights to AKCEA-APOCIII-LRx

                                
                                
Data from Phase 2 clinical trial of AKCEA-APOCIII-LRx anticipated i...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/16/1960829/0/en/Akcea-Therapeutics-Announces-New-Appointments-to-its-Board-of-Directors.html
                            

                                
Akcea Therapeutics Announces New Appointments to its Board of Directors

                                
                                
Lynne Parshall appointed chair and Barbara Yanni joins as new membe...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/general/biotech/19/12/14931993/12-biotech-stocks-primed-for-a-short-squeeze
                            

                                
12 Biotech Stocks Primed For A Short Squeeze

                                
                                
Biotech investment is risk fraught. Most biotech stocks are at the ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/04/1956070/0/en/Akcea-Announces-Appointment-of-New-Chief-Operating-Officer.html
                            

                                
Akcea Announces Appointment of New Chief Operating Officer

                                
                                
Alex Howarth joins Akcea from Lycera, bringing more than 25 years o...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/25/1951872/0/en/Akcea-and-Ionis-Announce-Initiation-of-NEURO-TTRansform-Phase-3-Clinical-Trial-for-AKCEA-TTR-LRx-in-Patients-with-Polyneuropathy-Driven-by-Hereditary-TTR-Amyloidosis.html
                            

                                
Akcea and Ionis Announce Initiation of NEURO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with Polyneuropathy Driven by Hereditary TTR Amyloidosis

                                
                                
BOSTON and CARLSBAD, Calif., Nov.  25, 2019  (GLOBE NEWSWIRE) -- Ak...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/19/1949713/0/en/Akcea-and-Ionis-Announce-Closing-of-Licensing-Agreement-with-Pfizer-Inc-for-Investigative-Antisense-Therapy-AKCEA-ANGPTL3-L-Rx.html
                            

                                
Akcea and Ionis Announce Closing of Licensing Agreement with Pfizer Inc. for Investigative Antisense Therapy AKCEA-ANGPTL3-L(Rx)

                                
                                
BOSTON and CARSLBAD, Calif., Nov.  19, 2019  (GLOBE NEWSWIRE) -- Ak...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4302908-akcea-therapeutics-inc-akca-ceo-damien-mcdevitt-q3-2019-results-earnings-call-transcript
                            

                                
Akcea Therapeutics, Inc. (AKCA) CEO Damien McDevitt on Q3 2019 Results - Earnings Call Transcript

                                
                                
Akcea Therapeutics, Inc. (AKCA) CEO Damien McDevitt on Q3 2019 Resu...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/605252/akcea-therapeutics-akca-reports-q3-loss-tops-revenue-estimates
                            

                                
Akcea Therapeutics (AKCA) Reports Q3 Loss, Tops Revenue Estimates

                                
                                
Akcea Therapeutics (AKCA) delivered earnings and revenue surprises ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2020/01/02/1965669/0/en/New-England-Journal-of-Medicine-Publishes-Results-from-Phase-2-Study-of-AKCEA-APO-a-LRx-in-Patients-with-Lp-a-driven-Cardiovascular-Disease.html
                            

                                
New England Journal of Medicine Publishes Results from Phase 2 Study of AKCEA-APO(a)-LRx in Patients with Lp(a)-driven Cardiovascular Disease

                                
                                
Patients treated with AKCEA-APO(a)-LRx received pre-specified endpo...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/19/1962553/0/en/Akcea-Retains-Rights-to-AKCEA-APOCIII-LRx.html
                            

                                
Akcea Retains Rights to AKCEA-APOCIII-LRx

                                
                                
Data from Phase 2 clinical trial of AKCEA-APOCIII-LRx anticipated i...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/16/1960829/0/en/Akcea-Therapeutics-Announces-New-Appointments-to-its-Board-of-Directors.html
                            

                                
Akcea Therapeutics Announces New Appointments to its Board of Directors

                                
                                
Lynne Parshall appointed chair and Barbara Yanni joins as new membe...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/general/biotech/19/12/14931993/12-biotech-stocks-primed-for-a-short-squeeze
                            

                                
12 Biotech Stocks Primed For A Short Squeeze

                                
                                
Biotech investment is risk fraught. Most biotech stocks are at the ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/04/1956070/0/en/Akcea-Announces-Appointment-of-New-Chief-Operating-Officer.html
                            

                                
Akcea Announces Appointment of New Chief Operating Officer

                                
                                
Alex Howarth joins Akcea from Lycera, bringing more than 25 years o...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/25/1951872/0/en/Akcea-and-Ionis-Announce-Initiation-of-NEURO-TTRansform-Phase-3-Clinical-Trial-for-AKCEA-TTR-LRx-in-Patients-with-Polyneuropathy-Driven-by-Hereditary-TTR-Amyloidosis.html
                            

                                
Akcea and Ionis Announce Initiation of NEURO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with Polyneuropathy Driven by Hereditary TTR Amyloidosis

                                
                                
BOSTON and CARLSBAD, Calif., Nov.  25, 2019  (GLOBE NEWSWIRE) -- Ak...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/19/1949713/0/en/Akcea-and-Ionis-Announce-Closing-of-Licensing-Agreement-with-Pfizer-Inc-for-Investigative-Antisense-Therapy-AKCEA-ANGPTL3-L-Rx.html
                            

                                
Akcea and Ionis Announce Closing of Licensing Agreement with Pfizer Inc. for Investigative Antisense Therapy AKCEA-ANGPTL3-L(Rx)

                                
                                
BOSTON and CARSLBAD, Calif., Nov.  19, 2019  (GLOBE NEWSWIRE) -- Ak...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4302908-akcea-therapeutics-inc-akca-ceo-damien-mcdevitt-q3-2019-results-earnings-call-transcript
                            

                                
Akcea Therapeutics, Inc. (AKCA) CEO Damien McDevitt on Q3 2019 Results - Earnings Call Transcript

                                
                                
Akcea Therapeutics, Inc. (AKCA) CEO Damien McDevitt on Q3 2019 Resu...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/605252/akcea-therapeutics-akca-reports-q3-loss-tops-revenue-estimates
                            

                                
Akcea Therapeutics (AKCA) Reports Q3 Loss, Tops Revenue Estimates

                                
                                
Akcea Therapeutics (AKCA) delivered earnings and revenue surprises ...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.